🔗 Share this article

Treasury head Reeves has revealed she is planning "specific measures to tackle household expense challenges" in the forthcoming Budget.

During an interview with the BBC, she emphasized that reducing price rises is a shared duty of both the administration and the central bank.

The United Kingdom's inflation rate is projected to be the highest among the G7 industrialized countries this year and next.

Potential Utility Bill Interventions

Reports indicate the administration could intervene to bring down utility costs, for example by cutting the present 5% rate of VAT charged on energy supplies.

An additional possibility is to cut some of the government charges currently included in household expenses.

Budgetary Limitations and Expert Predictions

The administration will obtain the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much scope there is for these measures.

The expectation from the majority of analysts is that Reeves will have to announce tax increases or spending cuts in order to fulfill her voluntary debt limits.

Previously on the same day, calculations indicated there was a £22bn gap for the chancellor to fill, which is at the lower end of forecasts.

"There's a joint task between the Bank of England and the administration to bear down further on some of the drivers of price increases," Reeves told the BBC in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Pledges and Global Concerns

While much of the focus has been on likely tax increases, the chancellor said the most recent information from the fiscal watchdog had not altered her vow to manifesto promises not to raise rates on earnings tax, sales tax or social security contributions.

She blamed an "unpredictable world" with growing geopolitical and commercial tensions for the Budget revenue measures, likely to be directed on those "with the broadest shoulders."

International Trade Disputes

Addressing worries about the UK's economic relations with the Asian nation she said: "The UK's security interests invariably take priority."

Recent announcement by Chinese authorities to increase export controls on critical minerals and other materials that are essential for high-technology production led American leader Donald Trump to propose an further 100% import tax on imports from the Asian country, increasing the prospect of an all-out commercial conflict between the two global powers.

The US Treasury Secretary described the Chinese action "commercial pressure" and "a global supply chain control attempt."

Inquired about accepting the US offer to join its conflict with the Asian nation, the Chancellor said she was "deeply worried" by China's measures and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "damaging for the international commerce and creates further obstacles."

"I believe there are fields where we need to challenge China, but there are also significant opportunities to trade with Chinese markets, including banking sector and other areas of the economic system. We've got to achieve that equilibrium correct."

The Treasury chief also confirmed she was working with G7 counterparts "regarding our own essential resources strategy, so that we are reduced dependence."

NHS Drug Costs and Funding

The Chancellor also acknowledged that the cost the NHS pays for drugs could go up as a result of current discussions with the US government and its drugs companies, in return for reduced taxes and funding.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either halting or scrapping projects in the UK, with some blaming the modest returns they are getting.

Last month, the government science advisor said the price the health service spends on drugs would need to rise to prevent companies and drug research funding leaving the UK.

Reeves informed media: "We have seen due to the payment system, that drug testing, recent pharmaceuticals have not been offered in the United Kingdom in the extent that they are in other continental states."

"The objective is to ensure that people getting care from the National Health Service are can access the top critical drugs in the globe. And so we are looking at this situation, and... seeking to secure more investment into Britain."